These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8294944)

  • 1. A Monte Carlo pharmacophore generation procedure: application to the human PAF receptor.
    Hodgkin EE; Miller A; Whittaker M
    J Comput Aided Mol Des; 1993 Oct; 7(5):515-34. PubMed ID: 8294944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacophore for high affinity PAF antagonists. II. Hydrophobicity study using the molecular lipophilicity potential.
    Le Solleu H; Laguerre M; Saux M; Dubost JP
    J Lipid Mediat Cell Signal; 1997 Jun; 16(2):75-113. PubMed ID: 9172050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships and effects of platelet-activating factor antagonists in the hetrazepine series.
    Weber KH; Heuer H
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):82-7. PubMed ID: 2540098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydrobenzofuran-6(2 H)-one Neolignans from Ocotea heterochroma: Their Platelet Activating Factor (PAF) Antagonistic Activity and in Silico Insights into the PAF Receptor Binding Mode.
    Rozo-Lugo C; Cuca-Suárez LE; Schmidt TJ; Coy-Barrera E
    J Nat Prod; 2018 Sep; 81(9):1968-1975. PubMed ID: 30188730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Cys90, Cys95 and Cys173 residues in the structure and function of the human platelet-activating factor receptor.
    Le Gouill C; Parent JL; Rola-Pleszczynski M; Stanková J
    FEBS Lett; 1997 Feb; 402(2-3):203-8. PubMed ID: 9037196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of N-glycosylation for functional expression of the human platelet-activating factor receptor. Glycosylation is required for efficient membrane trafficking.
    García Rodríguez C; Cundell DR; Tuomanen EI; Kolakowski LF; Gerard C; Gerard NP
    J Biol Chem; 1995 Oct; 270(42):25178-84. PubMed ID: 7559653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of specific platelet-activating factor binding-sites in neuroblastoma N1E-115 cells.
    Lalouette F; Diserbo M; Martin C; Verdetti J; Fatome M
    Neurosci Lett; 1995 Feb; 186(2-3):173-6. PubMed ID: 7777190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor.
    Brewer C; Bonin F; Bullock P; Nault MC; Morin J; Imbeault S; Shen TY; Franks DJ; Bennett SA
    J Neurochem; 2002 Sep; 82(6):1502-11. PubMed ID: 12354298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes.
    Marquis O; Robaut C; Cavero I
    J Pharmacol Exp Ther; 1988 Feb; 244(2):709-15. PubMed ID: 2831350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional validation of platelet-activating factor receptor sites characterized biochemically by a specific and reproducible [3H]platelet-activating factor binding in human platelets.
    Tahraoui L; Floch A; Cavero I
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1221-7. PubMed ID: 2156995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature dependence of [3H]PAF binding to washed human platelets.
    Borea PA; Montesi L; Muzzolini A; Fantozzi R
    Biochem Pharmacol; 1991 Feb; 41(4):629-30. PubMed ID: 1847638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel phomactin analogues as PAF receptor ligands.
    Goldring WP; Alexander SP; Kendall DA; Pattenden G
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3263-6. PubMed ID: 15922596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.
    Lee CM; Jiang LM; Shang HS; Hon PM; He Y; Wong HN
    Br J Pharmacol; 1991 Jul; 103(3):1719-24. PubMed ID: 1657264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alanine exchanges of polar amino acids in the transmembrane domains of a platelet-activating factor receptor generate both constitutively active and inactive mutants.
    Ishii I; Izumi T; Tsukamoto H; Umeyama H; Ui M; Shimizu T
    J Biol Chem; 1997 Mar; 272(12):7846-54. PubMed ID: 9065450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAF receptor structure: a hypothesis.
    Godfroid JJ; Dive G; Lamotte-Brasseur J; Batt JP; Heymans F
    Lipids; 1991 Dec; 26(12):1162-6. PubMed ID: 1668112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.
    Tahraoui L; Floch A; Mondot S; Cavero I
    Mol Pharmacol; 1988 Aug; 34(2):145-51. PubMed ID: 2842653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of an aspartate at position 63 in the human platelet-activating factor receptor augments binding affinity but abolishes G-protein-coupling and inositol phosphate production.
    Parent JL; Le Gouill C; Rola-Pleszczynski M; Stanková J
    Biochem Biophys Res Commun; 1996 Feb; 219(3):968-75. PubMed ID: 8645288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor in the CNS.
    Maclennan KM; Smith PF; Darlington CL
    Prog Neurobiol; 1996 Dec; 50(5-6):585-96. PubMed ID: 9015828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific binding sites for platelet activating factor in human lung tissues.
    Hwang SB; Lam MH; Shen TY
    Biochem Biophys Res Commun; 1985 Apr; 128(2):972-9. PubMed ID: 2986633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioligand competitive binding methodology for the evaluation of platelet-activating factor (PAF) and PAF-receptor antagonism using intact canine platelets.
    Janero DR; Burghardt B; Burghardt C
    J Pharmacol Methods; 1988 Nov; 20(3):237-53. PubMed ID: 2853256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.